Switching From Oral Dopamine Agonists to Rotigotine

NCT01976871 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Restless Legs Syndrome
Ekbom Syndrome
Willis-Ekbom Disease

Interventions

DRUG: Rotigotine

Sponsor

John Winkelman, MD, PhD

Collaborators

[object Object]